United Kingdom |
December 1998 |
The manufacturer of the antipsychotic medication, sertindole (serdolect) voluntarily suspended the availability of serdolect. This is because of concerns about reports of cardiac arrhythmias and sudden cardiac death associated with its use. (Reference: Message from Committee on Safety of Medicines, 2 December 1998.) |